Product Specific References for Applications and Species
Immunocytochemistry: Human | ||
PMID | Dilution | Publication |
31783139 | not listed | Yoshida, S., et al. 2019. MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma. Nanomedicine, 102127. |
28419087 | not listed | Duong, C., et al. 2017. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA. Pediatric Research, 527-535. |
25554682 | 1:1000 | Barisone, G.A., et al. 2015. Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells.. Blood Cells, Molecules, and Diseases, 329-335. |
25196579 | not listed | Satake, N., et al. 2014. Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.. British Journal of Haematology, 487-499. |
25053245 | not listed | Ngo, T., et al. 2014. MXD3 regulation of DAOY cell proliferation dictated by time course of activation.. BMC Cell Biology, 30. |
Western Blot: Human | ||
PMID | Dilution | Publication |
31783139 | not listed | Yoshida, S., et al. 2019. MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma. Nanomedicine, 102127. |
25554682 | 1:1000 | Barisone, G.A., et al. 2015. Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells.. Blood Cells, Molecules, and Diseases, 329-335. |
Western Blot: Xenopus | ||
PMID | Dilution | Publication |
21599922 | not listed | Carneiro, K., et al. 2011. Histone deacetylase activity is necessary for left-right patterning during vertebrate development.. BMC Developmental Biology, 29. |